Philip Troen
Mayo Clinic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Philip Troen.
The New England Journal of Medicine | 1980
Philip Troen; Hiroyuki Oshima
n The use of a specific radiolabeled antiglobulin test to detect antisperm antibodies has given positive results in 7% of infertile men and 13% of infertile women, and may be a reliable means of identifying and possibly treating patients whose infertility is caused by immune mechanisms. The importance of studying the infertile couple rather than the women only has been emphasized; the sparse data available suggest that deficiencies may occur in the man in as many as 1/2 of the estimated 10-15% of couples who are infertile. Most infertile men are still classified as having idiopathic oligospermia, implying sperm counts below those associated with ready fertility, without apparent cause. It is now clear that the fertility potential of both partners must be evaluated in assessing the importance of oligospermia, making assessment of the response to therapy more difficult. The diagnosis of oligospermia itself is beset by such difficulties as the variability of the sperm count at both normal and low levels and the overlap between presumed fertile and infertile levels of sperm. The maximum number of sperm necessary to define oligospermia has declined over recent years to 10 million sperm/ml. Oligospermia appears to represent a common response of the male reproductive system to a variety of insults. Most patients have abnormal pituitary responsiveness related to decreased feedback control of hypothalamus and pituitary by the testis. Altered testicular function is most likely when the sperm count is below 5 million/ml. Environmental factors, intrinsic testicular defects, and androgen insensitivity due to a decreased number of androgen receptors are other possible causes. The probable diversity of pathogenesis and the difficulty of obtaining properly controlled studies are reasons for the inconclusive results of most therapeutic efforts. However, significant progress in the understanding of testicular disorders in the past few years has led to an outburst of scientific and collegial activities related to andrology, and there is reasonable hope for a more definite understanding of male fertility in the near future.n
Clinical Chemistry and Laboratory Medicine | 1998
Henrik Olesen; Alexander Giwercman; David M. de Kretser; David Mortimer; Hiroyuki Oshima; Philip Troen
1) The exclusive
Archive | 1980
Shirley Siew; Philip Troen; Howard R. Nankin
The acrosome is a highly specialized membrane-enclosed, subcellular organelle, which is unique to the male reproductive system. Its nomenclature is derived from the Greek akron - extremity, top or summit - and soma - body - as it is normally situated at the anterior extremity, top or summit of the spermatozoon, where it occupies the space between the plasmalemma and the nuclear envelope. The inner acrosomal membrane is in juxtaposition to the nuclear membrane and the acrosome spreads over the anterior pole of the nucleus to cover it like a cap.
Archive | 1977
Philip Troen; Howard R. Nankin
The Journal of Clinical Endocrinology and Metabolism | 1983
Jun Takahashi; Yotsuo Higashi; Joseph A. Lanasa; Ken-Ichiro Yoshida; Stephen J. Winters; Hiroyuki Oshima; Philip Troen
The Journal of Clinical Endocrinology and Metabolism | 1975
Howard R. Nankin; Raul Pinto; Der-Fong Fan; Philip Troen
European Journal of Endocrinology | 1980
Masahiko Hosaka; Hiroyuki Oshima; Philip Troen
The Journal of Clinical Endocrinology and Metabolism | 1982
Jun Takahashi; Yotsuo Higashi; Joseph A. Lanasa; Stephen J. Winters; Hiroyuki Oshima; Philip Troen
The Journal of Clinical Endocrinology and Metabolism | 1980
Judy Lee; Ken-Ichiro Yoshida; Masahiko Hosaka; Deborah Stratico; An-Fei Hsu; Stephen J. Winters; Hiroyuki Oshima; Philip Troen
The Journal of Clinical Endocrinology and Metabolism | 1956
Philip Troen; Edward H. Rynearson